Press Releases

Date Title and Summary
Toggle Summary Capnia Announces Commencement of Series B Warrant Exchange Offer
REDWOOD CITY, Calif. , June 26, 2015 (GLOBE NEWSWIRE) -- Capnia, Inc. (Nasdaq:CAPN), focused on the development of novel products based on its proprietary technologies for precision metering of gas flow, today announced that its previously filed Registration Statement on Form S-4 in connection with
Toggle Summary Capnia to Present at 2015 Marcum MicroCap Conference
REDWOOD CITY, Calif. , May 21, 2015 (GLOBE NEWSWIRE) -- Capnia, Inc. (Nasdaq:CAPN), focused on the development of novel products based on its proprietary technologies for precision metering of gas flow, today announced that Anish Bhatnagar , M.D., Chief Executive Officer, will present at the 2015
Toggle Summary Capnia Reports First Quarter 2015 Financial Results
REDWOOD CITY, Calif. , May 4, 2015 (GLOBE NEWSWIRE) -- Capnia, Inc. (Nasdaq:CAPN), focused on the development of novel products based on its proprietary technologies for precision metering of gas flow, today announced financial results for the first quarter ended March 31, 2015 .
Toggle Summary Capnia Appoints Edward Ebbers as Chief Commercial Officer
REDWOOD CITY, Calif. , April 13, 2015 (GLOBE NEWSWIRE) -- Capnia, Inc. (Nasdaq:CAPN), focused on the development of novel products based on its proprietary technologies for precision metering of gas flow, today announced the appointment of Edward Ebbers as Chief Commercial Officer, effective today.
Toggle Summary Capnia Awarded NIH Grant to Develop Sickle Cell Anemia Screening in Developing Countries
Phase 1 SBIR Grant Supported by Scientific Data Recently Published in Journal Pediatric Blood & Cancer REDWOOD CITY, Calif. , April 6, 2015 (GLOBE NEWSWIRE) -- Capnia, Inc. (Nasdaq:CAPN), focused on the development of novel products based on its proprietary technologies for precision metering
Toggle Summary Capnia Reports Fourth Quarter and Full Year 2014 Financial Results
REDWOOD CITY, Calif. , March 10, 2015 (GLOBE NEWSWIRE) -- Capnia, Inc. (Nasdaq:CAPN), focused on the development of novel products based on its proprietary technologies for precision metering of gas flow, today announced financial results for the fourth quarter and twelve months ended December 31,
Toggle Summary Capnia Announces Receipt of $3.6 Million From Series B Warrant Exercise and Issuance of Series C Warrants
REDWOOD CITY, Calif. , March 5, 2015 (GLOBE NEWSWIRE) -- Capnia, Inc. (Nasdaq:CAPN), focused on the development of novel products based on its proprietary technologies for precision metering of gas flow, today announced the closing of a privately negotiated transaction (the "Private Transaction")
Toggle Summary Capnia Announces First U.S. Commercial Sales of CoSense(R)
REDWOOD CITY, Calif. , Feb. 17, 2015 (GLOBE NEWSWIRE) -- Capnia, Inc. (Nasdaq:CAPN), focused on the development of novel products based on its proprietary technologies for precision metering of gas flow, today announced the first U.S. commercial sales of the Company's CoSense End-Tidal Carbon
Toggle Summary Capnia Announces Publication of CoSense® Scientific Data in the Journal Blood Cells, Molecules and Diseases
REDWOOD CITY, Calif. , Jan. 28, 2015 /PRNewswire/ --  Capnia, Inc. (NASDAQ: CAPN), focused on the development of novel diagnostics and therapeutics based on its proprietary technologies for precision metering of gas flow, today announced a paper, titled "End-tidal carbon monoxide as an indicator of
Toggle Summary Capnia Applies for Orphan Drug Designation in the U.S. for the Treatment of Trigeminal Neuralgia
REDWOOD CITY, Calif. , Jan. 8, 2015 / PRNewswire / -- Capnia, Inc. (NASDAQ: CAPN), focused on the development of novel diagnostics and therapeutics based on its proprietary technologies for precision metering of gas flow, today announced that it has submitted an application to the U.S.